Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolylbenzene-1,3-diols for diseases associated with g protein-coupled receptor 18 and in combination with transient receptor potential vanilloid 1

Pyrazolylbenzene-1,3-diols for diseases associated with g protein-coupled receptor 18 and in combination with transient receptor potential vanilloid 1

US Patent 12091389 · Granted Sep 17, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Beta-arrestin-biased cannabinoid CB1 receptor agonists and methods for making an2020
Beta-arrestin-biased cannabinoid CB1 receptor agonists and methods for making an2020
Selective modulators of the activity of the GPR55 receptor: chromenopyrazole der2019
Beta-arrestin-biased cannabinoid CB1 receptor agonists and methods for making an2018
Beta-arrestin-biased cannabinoid CB1 receptor agonists and methods for making an2018
Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)2017
Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)2017
Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)2015
Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)2015
1,2,4-triazole derivatives as sigma receptor inhibitors2013
1,2,3-triazole derivatives as sigma receptor inhibitors2012
1,2,4-triazole derivatives as sigma receptor inhibitors2011